$XBIT
XBiotech Inc.

2021 Q4 Form 10-Q Financial Statement

#000117184321007731 Filed on November 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $4.500M $4.500M $4.525M
YoY Change -14.61% -57.34% -70.8%
Cost Of Revenue $1.046M $1.110M $1.360M
YoY Change -53.51% -88.22% -89.7%
Gross Profit $3.454M $3.409M $3.165M
YoY Change 14.37% 203.56% 37.79%
Gross Profit Margin 76.76% 75.76% 69.94%
Selling, General & Admin $1.866M $1.541M $4.516M
YoY Change -58.35% -55.33% -27.74%
% of Gross Profit 54.02% 45.2% 142.69%
Research & Development $8.782M $5.599M $9.254M
YoY Change 153.82% 138.66% 260.78%
% of Gross Profit 254.26% 164.24% 292.39%
Depreciation & Amortization $702.0K $687.0K $639.0K
YoY Change 18.98% 24.91% 18.33%
% of Gross Profit 20.32% 20.15% 20.19%
Operating Expenses $10.65M $7.139M $13.77M
YoY Change 34.11% 23.23% 56.28%
Operating Profit -$7.193M -$3.731M -$10.61M
YoY Change 46.14% -20.11% 62.8%
Interest Expense -$474.0K -$1.203M $916.0K
YoY Change -116.75% -181.28% -672.5%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.324M $914.0K
YoY Change -189.7% -238.07%
Pretax Income -$7.668M -$5.055M -$9.691M
YoY Change 266.89% 58.27% 35.05%
Income Tax -$1.201M -$1.800M -$4.570M
% Of Pretax Income
Net Earnings -$6.467M -$3.261M -$5.118M
YoY Change 251.85% 29.1% -25.22%
Net Earnings / Revenue -143.71% -72.47% -113.1%
Basic Earnings Per Share -$0.21 -$0.11 -$0.17
Diluted Earnings Per Share -$212.7K -$107.5K -$170.7K
COMMON SHARES
Basic Shares Outstanding 30.40M 30.38M 29.98M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.0M $238.9M $315.3M
YoY Change -0.18% 0.2% 37.25%
Cash & Equivalents $237.0M $238.9M $315.3M
Short-Term Investments
Other Short-Term Assets $934.0K $919.0K $1.471M
YoY Change -66.64% -8.1% -50.97%
Inventory
Prepaid Expenses
Receivables $0.00 $44.00K $25.00K
Other Receivables $8.953M $10.40M $8.109M
Total Short-Term Assets $246.9M $250.2M $324.9M
YoY Change -24.24% -0.58% 25.73%
LONG-TERM ASSETS
Property, Plant & Equipment $28.31M $28.64M $28.45M
YoY Change 3.55% 9.28% 14.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $642.0K $642.0K
YoY Change -100.0% 60.5% 60.5%
Total Long-Term Assets $28.31M $29.28M $29.09M
YoY Change 1.57% -71.21% -71.02%
TOTAL ASSETS
Total Short-Term Assets $246.9M $250.2M $324.9M
Total Long-Term Assets $28.31M $29.28M $29.09M
Total Assets $275.2M $279.5M $354.0M
YoY Change -22.21% -20.9% -1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.069M $1.012M $1.491M
YoY Change -16.94% -73.85% -71.55%
Accrued Expenses $1.374M $1.643M $1.681M
YoY Change 1.7% -28.75% -65.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.453M $3.861M $3.891M
YoY Change -13.33% -37.71% -72.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.466M $1.393M $1.393M
YoY Change 33.27% 26.64% 26.64%
Total Long-Term Liabilities $1.466M $1.393M $1.393M
YoY Change 33.27% 26.64% 26.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.453M $3.861M $3.891M
Total Long-Term Liabilities $1.466M $1.393M $1.393M
Total Liabilities $5.792M $5.362M $5.392M
YoY Change 13.46% -26.08% -64.51%
SHAREHOLDERS EQUITY
Retained Earnings $5.151M $11.62M $89.88M
YoY Change -94.72% -87.74% -7.64%
Common Stock $262.3M $260.9M $256.8M
YoY Change 4.99% 3.61% 4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $269.4M $274.2M $348.6M
YoY Change
Total Liabilities & Shareholders Equity $275.2M $279.5M $354.0M
YoY Change -22.21% -20.9% -1.34%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$6.467M -$3.261M -$5.118M
YoY Change 251.85% 29.1% -25.22%
Depreciation, Depletion And Amortization $702.0K $687.0K $639.0K
YoY Change 18.98% 24.91% 18.33%
Cash From Operating Activities -$1.759M -$3.402M $72.80M
YoY Change 351.03% -145.48% -729.18%
INVESTING ACTIVITIES
Capital Expenditures -$476.0K -$700.0K -$1.709M
YoY Change -78.56% 1.45% 297.44%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$476.0K -$700.0K -$1.709M
YoY Change -78.56% 1.45% 297.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 33.00K -72.04M 3.978M
YoY Change -122.0% -3330.45% 1320.71%
NET CHANGE
Cash From Operating Activities -1.759M -3.402M 72.80M
Cash From Investing Activities -476.0K -700.0K -1.709M
Cash From Financing Activities 33.00K -72.04M 3.978M
Net Change In Cash -2.202M -76.14M 75.06M
YoY Change -20.22% -944.14% -740.49%
FREE CASH FLOW
Cash From Operating Activities -$1.759M -$3.402M $72.80M
Capital Expenditures -$476.0K -$700.0K -$1.709M
Free Cash Flow -$1.283M -$2.702M $74.50M
YoY Change -170.11% -133.07% -768.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30399309
CY2021Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30397811
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29304396
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279519000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28640000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27336000 USD
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238877000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237366000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44000 USD
CY2021Q3 us-gaap Assets
Assets
279519000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
325875000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
642000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10549000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
533000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28640000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27336000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4113000 USD
CY2021Q3 xbit Escrow Receivable Current
EscrowReceivableCurrent
0 USD
CY2020Q4 xbit Escrow Receivable Current
EscrowReceivableCurrent
75063000 USD
CY2021Q3 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
544000 USD
CY2020Q4 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
2177000 USD
CY2021Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
10397000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6574000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
375000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
582000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
250237000 USD
CY2020Q4 us-gaap Assets
Assets
353744000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1012000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2491000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1643000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1351000 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1206000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
142000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3861000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3984000 USD
CY2021Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1393000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1121000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
108000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
5362000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
5105000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
260876000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
249805000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1663000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1266000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11618000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
97568000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
274157000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
348639000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353744000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4519000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13894000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
38728000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1110000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9426000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4774000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32300000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
3409000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
1123000 USD
us-gaap Gross Profit
GrossProfit
9120000 USD
us-gaap Gross Profit
GrossProfit
6428000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5599000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2346000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19486000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6066000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1541000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3447000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7522000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13716000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7139000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5793000 USD
us-gaap Operating Expenses
OperatingExpenses
27008000 USD
us-gaap Operating Expenses
OperatingExpenses
19782000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3731000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4670000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17888000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13354000 USD
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
125000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
124000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
357000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
2328000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-503000 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1328000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1352000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-127000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
794000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1324000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1476000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
98000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2619000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5055000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3194000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17790000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10735000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1794000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6843000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1352000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2526000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10947000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9383000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30341470
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29037074
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29921048
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31345760
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2526000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10947000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9383000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-240000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2169000 USD
CY2020Q3 xbit Common Stock Share Subscribed Value Issuance
CommonStockShareSubscribedValueIssuance
62000 USD
xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
108000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
397000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-322000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3501000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2817000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10550000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9705000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
348564000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-240000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2964000 USD
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
75003000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1133000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
274157000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
343570000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2526000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3155000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
346139000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
348639000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10947000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
397000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7962000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
75003000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3109000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
274157000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
755631000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9383000 USD
xbit Shares Buyback Equity Impact Amount
SharesBuybackEquityImpactAmount
420000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-322000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
xbit Common Stock Share Subscribed Value Issuance
CommonStockShareSubscribedValueIssuance
10426000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9787000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
346139000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10947000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9383000 USD
us-gaap Depreciation
Depreciation
1946000 USD
us-gaap Depreciation
Depreciation
1652000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3109000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9787000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4069000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6062000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3823000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
6110000 USD
xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-1633000 USD
xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
643000 USD
xbit Amount Held In Escrow
AmountHeldInEscrow
75063000 USD
xbit Amount Held In Escrow
AmountHeldInEscrow
-58000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-207000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1230000 USD
xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1679000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1874000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
292000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
542000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4500000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1334000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
108000 USD
xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
-49339000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71204000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64758000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3049000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1509000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3049000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1509000 USD
xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
0 USD
xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
-420000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
75003000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7962000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10426000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67041000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-409574000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
397000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-322000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1511000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-476163000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
237366000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
714594000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
238877000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
238431000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
202000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1179000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238900000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported values of amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5327425
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
162000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9787000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1134000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3155000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3109000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.87 pure
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.17
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.05
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentrations of Credit Risk </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents. The Company holds these investments in highly-rated financial institutions, and limits the amounts of credit exposure to any <em style="font: inherit;">one</em> financial institution. These amounts at times <em style="font: inherit;"> may </em>exceed federally insured limits. The Company has <em style="font: inherit;">not</em> experienced any credit losses in such accounts and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on these funds. The Company has <em style="font: inherit;">no</em> off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1093415
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
114374
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4500000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13900000 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
420000000.0 USD
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14000000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 xbit Stock Repurchased During Period Price Per Share
StockRepurchasedDuringPeriodPricePerShare
30
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
420000000.0 USD
CY2020Q1 xbit Percentage Of Outstanding Shares Repurchased
PercentageOfOutstandingSharesRepurchased
0.3267 pure
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1800000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10300000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1100000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8000000.0 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4281636
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4300000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
27000 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29037074
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29921048
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31345760
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M20D
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2526000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10947000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9383000 USD
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30341470
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1800000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209 pure
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.126 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.385 pure
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2400000 USD
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
271000 USD

Files In Submission

Name View Source Status
0001171843-21-007731-index-headers.html Edgar Link pending
0001171843-21-007731-index.html Edgar Link pending
0001171843-21-007731.txt Edgar Link pending
0001171843-21-007731-xbrl.zip Edgar Link pending
ex_302708.htm Edgar Link pending
ex_302709.htm Edgar Link pending
ex_302710.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xbit-20210930.xsd Edgar Link pending
xbit-20210930_cal.xml Edgar Link unprocessable
xbit-20210930_def.xml Edgar Link unprocessable
xbit-20210930_lab.xml Edgar Link unprocessable
xbit-20210930_pre.xml Edgar Link unprocessable
xbit20210930_10q.htm Edgar Link pending
xbit20210930_10q_htm.xml Edgar Link completed